Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Broto

Showing results (481-490 of 555) with videos related to

Pageof 56
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on SarcomasPaolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2015
Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in GuineaJean Marie Cournac, Ludovic Karkowski, Julien Bordes, et al.
Npj Urban Sustainability|June 16, 2023
Integration of urban science and urban climate adaptation research: opportunities to advance climate actionJosé Lobo, Rimjhim M Aggarwal, Marina Alberti, et al.
Lancet (London, England)|June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Cancer|March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupLorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|March 11, 2017
[Early clinical trials in paediatric oncology in Spain: a nationwide perspective]Francisco Bautista, Soledad Gallego, Adela Cañete, et al.
JAMA Oncology|October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus ReviewCésar Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
Tropical Medicine and Infectious Disease|July 28, 2023
Adherence and Toxicity during the Treatment of Latent Tuberculous Infection in a Referral Center in SpainJuan David Puyana Ortiz, Andrea Carolina Garcés Rodríguez, María Luisa Aznar, et al.
International Journal of Environmental Research and Public Health|July 26, 2020
Assessing the Pilot Implementation of the Integrated Multimorbidity Care Model in Five European Settings: Results from the Joint Action CHRODIS-PLUSCarmen Rodriguez-Blazquez, Maria João Forjaz, Antonio Gimeno-Miguel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma StudyJavier Martin-Broto, Antonio López Pousa, Ramón de Las Peñas, et al.
Pageof 56

Showing results (481-490 of 555) with videos related to

Sort By:
Pageof 56
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2015
Time to Definitive Failure to the First Tyrosine Kinase Inhibitor in Localized GI Stromal Tumors Treated With Imatinib As an Adjuvant: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Intergroup Randomized Trial in Collaboration With the Australasian Gastro-Intestinal Trials Group, UNICANCER, French Sarcoma Group, Italian Sarcoma Group, and Spanish Group for Research on SarcomasPaolo G Casali, Axel Le Cesne, Andres Poveda Velasco, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 5, 2015
Rhabdomyolysis in Ebola Virus Disease. Results of an Observational Study in a Treatment Center in GuineaJean Marie Cournac, Ludovic Karkowski, Julien Bordes, et al.
Npj Urban Sustainability|June 16, 2023
Integration of urban science and urban climate adaptation research: opportunities to advance climate actionJosé Lobo, Rimjhim M Aggarwal, Marina Alberti, et al.
Lancet (London, England)|June 24, 2019
Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trialWilliam D Tap, Hans Gelderblom, Emanuela Palmerini, et al.
Cancer|March 5, 2020
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupLorenzo D'Ambrosio, Nathan Touati, Jean-Yves Blay, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|March 11, 2017
[Early clinical trials in paediatric oncology in Spain: a nationwide perspective]Francisco Bautista, Soledad Gallego, Adela Cañete, et al.
JAMA Oncology|October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus ReviewCésar Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
Tropical Medicine and Infectious Disease|July 28, 2023
Adherence and Toxicity during the Treatment of Latent Tuberculous Infection in a Referral Center in SpainJuan David Puyana Ortiz, Andrea Carolina Garcés Rodríguez, María Luisa Aznar, et al.
International Journal of Environmental Research and Public Health|July 26, 2020
Assessing the Pilot Implementation of the Integrated Multimorbidity Care Model in Five European Settings: Results from the Joint Action CHRODIS-PLUSCarmen Rodriguez-Blazquez, Maria João Forjaz, Antonio Gimeno-Miguel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 18, 2016
Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma StudyJavier Martin-Broto, Antonio López Pousa, Ramón de Las Peñas, et al.
Pageof 56